Wester, R., van der Holt, B., Asselbergs, E., Zweegman, S., Kersten, M. J., Vellenga, E., Kooy, M. van M., de Weerdt, O., Minnema, M., Lonergan, S., Palumbo, A., Lokhorst, H., Broijl, A. and Sonneveld, P. (2019) “Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial”, Haematologica. Pavia, Italy, 104(11), pp. 2265-2273. doi: 10.3324/haematol.2018.205476.